- 精神分裂症遗传风险与智商降低关...
- 非典型抗精神病药在青少年使用性...
- 产前服用抗癫痫药物丙戊酸钠增加...
- 老年患者使用抗精神病药要注意的
- 抗高血压药物硝普钠适用治疗精神...
- 吃出好心情
- 叶酸和精神疾病
- 5个简单问题预测精神病人的暴力...
- 门冬氨酸受体抗体在精神分裂症升...
- ω- 3脂肪酸和精神疾病
- 孕烯醇酮治疗精神分裂症的可能性
- 硝普钠迅速缓解精神分裂症的症状
- 痴呆的补充和替代疗法
- 产前服用抗癫痫药物丙戊酸钠增加...
- 噩梦的失眠可以关联抑郁症患者自...
- 睡眠质量预测临床前阿尔茨海默氏...
- 以色列科学家找出精神分裂症新的...
- (转)“灾难”让临床心理学家学...
- 治疗焦虑障碍的失眠
- 大脑中谷氨酸增高致精神分裂症
- 双相抑郁治疗和预防国际共识
- 多基因因素导致精神分裂症风险
- 精神分裂症的复发常有更多的尿路...
- 世界卫生组织对中国(H7N9)...
- 治疗强迫症的药物
- 非典型抑郁的诊断与治疗
- 对尚不能诊断为精神分裂症或精神...
- 治疗精神分裂症的问题(颜文伟)
- 快乐睡眠
- 光治疗改善老年抑郁症
- 催产素改善孤独症
- 经颅磁刺激治疗改善精神分裂症的...
- 轻度躯体异态可能反映出精神分裂...
- 精神分裂症与双相障碍的神经软体...
- 精神分裂症早期就要预防代谢疾病...
- 社交功能损害可能是精神分裂症早...
- 儿童双相障碍往往首发为抑郁症状
- 双相情感障碍和精神分裂症的社会...
- 精神分裂症患者并发症和死亡
- 怀孕期间使用SSRI死胎和新生...
- “抗氧化剂对有遗传脆弱性精神分...
- 血锂浓度正常的锂中毒 (喻东山...
- 补充叶酸和维生素B12可改善精...
- 赌博成瘾显示大脑白质异常类似物...
- 苯二氮卓类与致命的肺炎相关联
- FDA推荐低剂量唑吡坦用于失眠...
- 双相情感障碍存在代谢综合征危险...
- NMDA受体的抗抑郁作用
- 抗精神病药物的抗抑郁效果
- 焦虑症状的自我改善
- FDA requires sl...
- 未被发现的疾病增加精神分裂症的...
- 补充维生素C增加男性肾结石的风...
- FDA-approved me...
- 精神分裂症的不良饮食习惯易引起...
- 难治性精神分裂症与种族
- 难治性精神分裂症
- 精神病治疗的新方法
- 抗抑郁药物撤药症状
- 服用SSRIs增加脑出血的风险
- 童年急性应激增加精神障碍的风险
- 空气污染与儿童孤独症
- 酒精依赖的康复
- 处理酒精戒断症状
- The average lif...
- 证据显示突变基因引发精神分裂症
- 治疗强迫症
- 治疗强迫症进展
- 饮食与精神健康
- 膳食补充剂对精神分裂症的预防提...
- 服抗精神病药前需要向医生问些什...
- 治疗焦虑症的药物
- 治疗双相障碍的药物
- 治疗精神分裂症的药物
- 非典型抗精神病药对儿童情感障碍...
- 研究提示:青少年双相障碍患病率...
- 能对抗抑郁药快速反应的脑中的生...
- 迅速短暂缓解抑郁的研究
- FDA对安眠药唑吡坦提出安全警...
- 联合使用抗抑郁药
- 精神疾病急性期治疗
- 精神疾病急性期治疗
- 使用抗精神病药基本原则
- 拮抗大脑中的谷氨酸盐可以防止自...
- 起效迅速 疗效持久的抗抑郁药问...
- 缺乏共情可能是精神障碍的特点
- 抑郁症患者中有不少是双相障碍
- 在中国文化程度低患精神分裂症的...
- 认识不够使治疗双相障碍治疗时间...
- 亚临床的双相抑郁
- 妊娠早期精神压力过大,增加孩子...
- 精神分裂症疗效不好时?
- FDA-批准的治疗酒精依赖药物
- “毒品”疫苗:药物依赖令人激动...
- 治疗迟发性运动障碍
- 美国食品和药物管理局批准另一个...
- 妊娠期是否服用抗抑郁药:一个艰...
- 睡眠不足会导致精神分裂症的症状...
- 精神障碍的危险因素与保护因素
- 缓解强迫症
- 大脑训练可以帮助提高老年人特定...
- 大脑训练可以帮助提高老年人特定...
- 科学解释:人们在得到鼓励后为何...
- 老年人服用苯二氮卓类药物可能增...
- 老年人服用苯二氮卓类药物可能增...
- 运动有益于精神分裂症患者的身体...
- 运动有益于精神分裂症患者的身体...
- 预防老年痴呆
- 预防老年痴呆
- 科学家荣获2012精神医学研究...
- 科学家荣获2012精神医学研究...
- 2011年美国农业部和美国卫生...
- 2011年美国农业部和美国卫生...
- 美国食品和药物管理局批准使用的...
- 美国食品和药物管理局批准使用的...
- 美国的各类精神障碍患者数量及患...
- 美国的各类精神障碍患者数量及患...
- 精神分裂症的早期征象
- 精神分裂症的早期征象
- 精神疾病与季节
- 精神疾病与季节
- 使人心情抑郁的十种药
- 使人心情抑郁的十种药
- 叶酸与抑郁症
- 叶酸与抑郁症
- 欧洲药品管理局建议降低西太普兰...
- 欧洲药品管理局建议降低西太普兰...
- 增加点维生素D可以减轻抑郁
- 增加点维生素D可以减轻抑郁
- 抗精神病药疗效降低的可能原因 ...
- 抗精神病药疗效降低的可能原因 ...
- 精神分裂症复发的早期表现
- 精神分裂症复发的早期表现
- 降低精神分裂症患病风险的策略
- 降低精神分裂症患病风险的策略
- 基因不是命运
- 基因不是命运
- 阿尔茨海默氏症治疗
- 缓解精神压力小技巧
- 缓解精神压力小技巧
- 抗抑郁药临床治疗的选择[转载]
- 抗抑郁药临床治疗的选择[转载]
- 对精神疾病一些认识误区 (摘...
- 对精神疾病一些认识误区 (摘...
- 精神病药物疗效差的可能因素
- 精神病药物疗效差的可能因素
- 识别精神病的早期症状
- 识别精神病的早期症状
- 引起或诱发双相障碍的原因
- 引起或诱发双相障碍的原因
- the potential f...
- the potential f...
- 抑郁症与低胆固醇
- 抑郁症与低胆固醇
- 抑郁症复发的高危因素
- 抑郁症复发的高危因素
- 抗抑郁药物的停药一些问题
- 抗抑郁药物的停药一些问题
- 儿童孤独症的药物治疗
- 儿童孤独症的药物治疗
- 精神分裂症巩固期的合并用药
- 精神分裂症巩固期的合并用药
- Psychotropic Me...
- Psychotropic Me...
- ECT的副反应
- ECT的副反应
- 双相障碍药物长期治疗的一些问题
- 双相障碍药物长期治疗的一些问题
- 电休克治疗中 adequate...
- 电休克治疗中 adequate...
- 治疗迟发性运动障碍的药物
- 治疗迟发性运动障碍的药物
- 如何睡的更好
- 如何睡的更好
- 草药能否治疗抑郁症?
- 草药能否治疗抑郁症?
- 季节性情感障碍
- 季节性情感障碍
- 一小时内缓解抑郁症(Scien...
- 一小时内缓解抑郁症(Scien...
- 患双相情感障碍年轻女性在服用丙...
- 患双相情感障碍年轻女性在服用丙...
- 妊娠期电休克治疗的安全性
- 妊娠期电休克治疗的安全性
- 阿尔茨海默氏症治疗
- 作者:朱健民|发布时间:2012-08-16|浏览量:463次
Alzheimer"s Treatment
Although there is currently no way to cure Alzheimer"s disease or stop its progression, researchers are making encouraging advances in Alzheimer"s treatment, including medications and non-drug approaches to improve symptom management. When physicians develop treatment plans, they often consider cognitive and beh avioral symptoms separately. 江西省精神病医院精神科朱健民
Cognitive symptoms include problems with thought processes like memory, language, and judgment. Two kinds of medications have been approved by the U.S. Food and Drug Administration for treatment of cognitive symptoms of Alzheimer"s disease: Cholinesterase inhibitors increase the levels of acetylcholine in the brain, which plays a key role in memory and learning. This kind of drug postpones the worsening of symptoms for 6 to 12 months in about half of the people who take it. Cholinesterase inhibitors most commonly prescribed for mild to moderate Alzheimer"s disease include Aricept (donezepil HCL), Exelon (rivastigmine), and Razadyne (galantamine). Because of varying side effects and possible interactions with other medications, doctors may try different cholinesterase inhibitors until the most effective one is found for the individual.
•Namenda (memantine) regulates glutamate in the brain, which plays a key role in processing information. This drug is used to treat moderate to severe Alzheimer"s disease and may delay the worsening of symptoms in some people.
Cholinesterase inhibitors can be started as soon as Alzheimer"s symptoms appear -- in fact, they are most effective in the early stages of the disease. When a physician determines that the cholinesterase inhibitor is no longer effective, he or she often recommends tapering off the cholinesterase inhibitor and introducing memantine. Sometimes, memantine and a cholinesterase inhibitor are taken simultaneously during the moderate stage of the disease.
Behavioral Symptoms
Often the most challenging for caregivers, behavioral symptoms include agitation, suspicion, and depression. Although caregivers often take personally the behaviors exhibited toward them, it"s important to remember that behavioral symptoms are just as much a result of damage to brain cells as are cognitive symptoms.
Some medications are useful for managing behavioral symptoms. For instance, anti-anxiety medications can treat agitation and aggression, while anti-psychotic medications have been used to address suspicion and paranoia. However, the risk of drug reactions and/or interactions runs high among those with Alzheimer"s, so caution should be used when medications are prescribed to deal with behavioral issues. A combination of drug and non-drug treatments often works best.
Non-drug treatments involve analyzing the behavior, identifying what may have triggered it, and devising an approach that either changes the person"s environment or the caregiver"s reaction to the behavior.
For example, excessive noise can worsen agitation in individuals with Alzheimer"s. Simply creating a calmer environment may eliminate the behavior. Likewise, when caregivers become angry in response to a difficult behavior, this usually only upsets the person with Alzheimer"s and increases the behavior"s frequency. Reacting in a calm, controlled manner can reduce the tension long enough to distract the person to a more pleasant activity, such as looking at a family photo album or listening to a favorite kind of music.
While physicians are skilled at prescribing medications to treat behavioral symptoms, they may not be familiar with non-drug interventions. Most caregivers learn about behavior management through their own research and by connecting with other caregivers through support groups and online support networks.
TA的其他文章: